GnRH receptor and apoptotic signaling

Ackerman, 1994, Induction of apoptotic or lytic death in an ovarian adenocarcinoma cell line by antibodies generated against a synthetic N-terminal extracellular domain gonadotropinreleasing hormone receptor peptide, Cancer Lett., 81, 177, 10.1016/0304-3835(94)90200-3

Aharoni, 1995, cAMP-mediated signals as determinants for apoptosis in primary granulosa cells, Exp. Cell Res., 218, 271, 10.1006/excr.1995.1156

Allen, 1998, Mechanisms controlling cellular suicide: Role of Bcl-2 and caspases, Cell. Mol. Life Sci., 54, 427, 10.1007/s000180050171

Amsterdam, 1994, Role of phospholipase-D and phosphatidic acid in mediating gonadotropin-releasing hormone-induced inhibition of preantral granulosa cell differentiation, Endocrinology, 135, 1205, 10.1210/en.135.3.1205

Arcaro, 1993, Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses, Biochem. J., 296, 297, 10.1042/bj2960297

Bamberger, 1997, Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells, J. Clin. Endocrinol. Metab., 82, 3173, 10.1210/jc.82.9.3173

Bilderback, 1997, Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae, J. Biol. Chem., 272, 10922, 10.1074/jbc.272.16.10922

Billig, 1996, Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: Biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells, Endocrinology, 134, 245, 10.1210/en.134.1.245

Blumenfeld, 1997, Prevention of gonadal damage during cytotoxic therapy, Ann. Med., 29, 199, 10.3109/07853899708999337

Blumenfeld, 1997, Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy, Hum. Reprod., 11, 1620, 10.1093/oxfordjournals.humrep.a019457

Bruckner, 1992, Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue, Am. J. Obstet. Gynecol., 161, 1216, 10.1016/0002-9378(89)90669-8

Carpenter, 1990, Phosphoinositide kinases, Biochemistry, 29, 11147, 10.1021/bi00503a001

Chang, 1987, Dynamic actions of arachidonic acid and protein kinase C in pituitary stimulation by gonadotropin-releasing hormone, Endocrinology, 120, 1837, 10.1210/endo-120-5-1837

Chatzaki, 1996, The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor, Cancer Res., 56, 2059

Cifone, 1994, Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase, J. Exp. Med., 177, 1547, 10.1084/jem.180.4.1547

Cifone, 1995, Multiple pathways originate at the Fas/Apo-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal, EMBO J., 14, 5859, 10.1002/j.1460-2075.1995.tb00274.x

Cohen, 1995, Modular binding domains in signal transduction proteins, Cell, 80, 237, 10.1016/0092-8674(95)90406-9

Comaru-Schally, 1998, Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia, J. Clin. Endocrinol. Metab., 83, 3826, 10.1210/jc.83.11.3826

Conn, 1994, Gonadotropin-releasing hormone and its analogs, Annu. Rev. Med., 45, 391, 10.1146/annurev.med.45.1.391

Crawford, 1990, Hormonal therapy of prostatic carcinoma, Oncology, 66, 1035

Dhanasekaran, 1995, G protein-coupled receptor systems involved in cell growth and oncogenesis, Endocr Rev., 16, 259, 10.1210/edrv-16-3-259

Dhein, 1992, Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens, J. Immunol., 149, 3166

Divecha, 1995, Phospholipid signaling, Cell, 80, 269, 10.1016/0092-8674(95)90409-3

Dobrowsky, 1992, Ceramide stimulates a cytosolic protein phosphatase, J. Biol. Chem., 267, 5048, 10.1016/S0021-9258(18)42727-5

Dondi, 1996, Growth factors in steroid-responsive prostatic tumor cells, Steroids, 61, 222, 10.1016/0039-128X(96)00018-9

Dou, 1996, Suppression of transforming growth factor-β (TGFβ) and TGFβ receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy, J. Clin. Endocrinol. Metab., 81, 3222, 10.1210/jc.81.9.3222

Emons, 1993, High affinity binding and direct antiproliferative effect of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines, J. Clin. Endocrinol. Metab., 77, 1458, 10.1210/jc.77.6.1458

Emons, 1994, The use of luteinizing hormone releasing hormone agonists and antagonists in gynecological cancers, Hum. Reprod. Update, 9, 1364, 10.1093/oxfordjournals.humrep.a138714

Exton, 1997, Phospholipase D: Enzymology, mechanisms of regulation, and function, Physiol Rev., 77, 303, 10.1152/physrev.1997.77.2.303

Fantl, 1993, Signalling by receptor tyrosine kinases, Annu. Rev. Biochem., 62, 453, 10.1146/annurev.bi.62.070193.002321

Farschon, 1997, Temporal phases in apoptosis defined by the actions of Src homology 2 domains, ceramide, Bcl-2, interleukin-1beta converting enzyme family proteases, and a dense membrane fraction, J. Cell Biol., 137, 1117, 10.1083/jcb.137.5.1117

Fischer, 1991, Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes, Science, 253, 401, 10.1126/science.1650499

Florio, 1992, Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity, J. Biol. Chem., 267, 24169, 10.1016/S0021-9258(18)35744-2

Flucker, 1991, Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle, J. Clin. Endocrinol. Metab., 72, 912, 10.1210/jcem-72-4-912

Friesen, 1996, Involvement of the CD95 (Apo1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells, Nat. Med., 2, 574, 10.1038/nm0596-574

Gallagher, 1991, Anew treatment for endometrial cancer with gonadotropin releasing-hormone analogue, Br. J. Obstet. Gynecol., 98, 1037, 10.1111/j.1471-0528.1991.tb15343.x

Garcia-Geralt, 1993, A phase-II-trial with D-trp-6 (decapeptyl) in premenopausal RH+, hormonal untreated breast cancer patient, Gynecol. Endocrinol., 7, 68

Gearing, 1994, Processing of tumor necrosis factor-α precursor by metalloproteinases, Nature, 370, 555, 10.1038/370555a0

Ghahremani, 1998, Activation of Fas ligand/receptor system kills ovarian cancer cell lines by an apoptotic mechanism, Gynecol. Oncol., 70, 275, 10.1006/gyno.1998.5091

Gonzalez-Barcena, 1989, Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancer, Biomed. Pharmacother., 43, 313, 10.1016/0753-3322(89)90014-0

Gonzalez-Barcena, 1995, LHRH antagonist SB-75 (Cetrorelix) as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord, Urology, 45, 275, 10.1016/0090-4295(95)80018-2

Hakuno, 1996, Fas/APO-1/CD-95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia, Endocrinology, 137, 1938, 10.1210/en.137.5.1938

Hammond, 1992, Phosphoamino acid phosphatases in normal and cancerous tissues of the human uterus, cervix and ovary, Arch. Int. Physiol. Biochim. Biophys., 100, 105, 10.3109/13813459209035268

Hannun, 1995, The sphingomyelin cycle and the second messenger function of ceramide, J. Biol. Chem., 269, 3125, 10.1016/S0021-9258(17)41834-5

Hannun, 1996, Functions of ceramide in coordinating cellular responses to stress, Science, 274, 1855, 10.1126/science.274.5294.1855

Heldin, 1995, Dimerization of cell surface receptors in signal transduction, Cell, 80, 213, 10.1016/0092-8674(95)90404-2

Herr, 1997, Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis, EMBO J, 16, 6200, 10.1093/emboj/16.20.6200

Hetts, 1998, To die or not to die: An overview of apoptosis and its role in disease, JAMA, 279, 300, 10.1001/jama.279.4.300

Higashijima, 1996, Gonadotropinreleasing hormone agonist therapy induces apoptosis in uterine leiomyoma, Eur. J. Obstet. Gynecol. Reprod. Biol., 68, 169, 10.1016/0301-2115(96)02504-3

Horinouchi, 1995, Acid sphingomyelinase deficient mice: Amodel of types A and B Niemann-Pick disease, Natl. Genet., 10, 288, 10.1038/ng0795-288

Hsieh, 1992, Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to guanosine triphosphate-binding proteins Gq and G11, Mol. Endocrinol., 6, 1673, 10.1210/me.6.10.1673

Hsueh, 1996, Gonadal cell apoptosis, Recent Prog. Horm. Res., 51, 433

Huang, 1998, Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist, Am. J. Obstet. Gynecol., 177, 417, 10.1016/S0002-9378(97)70208-4

Huckle, 1988, Molecular mechanism of gonadotropin releasing hormone action II: The effector system, Endocr Rev., 9, 387, 10.1210/edrv-9-4-387

Hug, 1997, Fas-mediated apoptosis in tumor formation and defense, Biol. Chem., 378, 1405

Hunter, 1995, Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling, Cell, 80, 225, 10.1016/0092-8674(95)90405-0

Husain, 1998, Coexpression of Fas ligand in malignant glial tumors and cell lines, Acta Neuropathol., 95, 287, 10.1007/s004010050799

Imai, 1992, Tight coupling of gonadotropin-releasing hormone receptor to stimulated phosphoinositide turnover and antigonadotropic action in granulosa cells, Gynecol. Obstet. Invest., 33, 36, 10.1159/000294844

Imai, 1993, Gonadotropin-releasing hormone has a biphasic action on aromatase activity through protein kinase C in granulosa cells, Int. J. Fertil., 38, 50

Imai, 1993, Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/dephosphorylation in plasma membrane from human epithelial ovarian cancer, Int. J. Gynecol. Cancer, 3, 311, 10.1046/j.1525-1438.1993.03050311.x

Imai, 1996, Signal transduction of GnRH receptor in the reproductive tract tumor, Endocr. J., 43, 249, 10.1507/endocrj.43.249

Imai, 1996, Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors, J. Clin. Endocrinol. Metab., 81, 3249, 10.1210/jc.81.9.3249

Imai, 1997, Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors, Eur. J. Obstet. Gynecol. Reprod. Biol., 74, 73, 10.1016/S0301-2115(97)02750-4

Imai, 1997, Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma, Am. J. Obstet. Gynecol., 176, 371, 10.1016/S0002-9378(97)70501-5

Imai, 1998, Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: Possible mechanism for hormonal control of apoptotic cell death, J. Clin. Endocrinol. Metab., 83, 427, 10.1210/jc.83.2.427

Imai, 1998, Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells, Int. J. Oncol., 13, 97

Irmer, 1994, Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines, J. Clin. Endocrinol. Metab., 79, 916, 10.1210/jc.79.3.916

Itoh, 1991, The polypeptide encoded by the cDNAfor human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233, 10.1016/0092-8674(91)90614-5

Iversen, 1990, Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer, Cancer, 66, 1067, 10.1002/cncr.1990.66.s5.1067

Jarvis, 1995, Induction of apoptotic damage and cell death by activation of the sphingomyelin pathway, 91, 73

Kaipia, 1996, Tumor necrosis factor-alpha and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles, Endocrinology, 137, 4864, 10.1210/en.137.11.4864

Kaiser, 1994, Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct, Mol. Endocrinol., 8, 1038, 10.1210/me.8.8.1038

Kakar, 1998, Inhibition of growth and proliferation of EcRG293 cell line expressing high-affinity gonadotropin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonists (D-Lys6)GnRH and antagonist (Antide), Cancer Res., 58, 4558

Kakar, 1994, The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary, Mol. Cell. Endocrinol., 106, 145, 10.1016/0303-7207(94)90196-1

Kakar, 1995, Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues, Cancer Lett., 98, 57, 10.1016/0304-3835(95)04012-S

Kapeller, 1994, Phosphatidylinositol 3-kinase, Bioessays, 16, 565, 10.1002/bies.950160810

Keutmann, 1992, Receptor-binding regions in human glycoprotein hormones, Mol. Cell. Endocrinol., 88, C1, 10.1016/0303-7207(92)90168-6

Khwaja, 1997, Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway, EMBO J., 16, 2783, 10.1093/emboj/16.10.2783

Kleinman, 1994, Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis, Am. J. Obstet. Gynecol., 170, 96, 10.1016/S0002-9378(94)70391-4

Kolesnick, 1995, Ceramide: A signal for apoptosis or mitogenesis?, J. Exp. Med., 181, 1949, 10.1084/jem.181.6.1949

Krsmanovic, 1993, Expression of gonadotropin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypothalamic neurons, 90, 3908

Lacal, 1997, Regulation of proliferation and apoptosis by Ras and Rho GTPase through specific phospholipid-dependent signaling, FEBS Lett., 410, 73, 10.1016/S0014-5793(97)00444-4

Lee, 1991, Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin or phosphorylation and dephosphorylation of tyrosine residues of specific substrates in various tumors, 88, 1656

Leung, 1992, Intracellular signaling in the gonads, Endocr. Rev., 13, 476

Liebow, 1991, Regulation of luteinizing hormonereleasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation, 88, 2244

Limonta, 1992, Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaR, J. Clin. Endocrinol. Metab., 75, 207, 10.1210/jc.75.1.207

Lin, 1995, Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion, J. Clin. Endocrinol. Metab., 80, 580, 10.1210/jc.80.2.580

Liscovitch, 1989, Gonadotropin-releasing hormone activates phospholipase D in ovarian granulosa cells, J. Biol. Chem., 264, 11762, 10.1016/S0021-9258(18)80131-4

Liscovitch, 1994, Lipid second messengers, Cell, 77, 329, 10.1016/0092-8674(94)90148-1

Liu, 1995, Compartmentalized production of ceramide at the cell surface, J. Biol. Chem., 270, 27179, 10.1074/jbc.270.45.27179

Loop, 1995, Growth inhibition of human prostate tumor cells by an agonist of gonadotropin-releasing hormone, Prostate, 26, 179, 10.1002/pros.2990260403

Maher, 1993, Activation of phosphotyrosine phosphatase activity by reduction of cellsubstrate adhesion, 90, 11177

Majerus, 1992, Inositol phosphate biochemistry, Annu. Rev. Biochem., 61, 225, 10.1146/annurev.bi.61.070192.001301

Manni, 1986, Treatment of breast cancer with gonadotropin-releasing hormone, Endocr Rev., 7, 89, 10.1210/edrv-7-1-89

Marchetti, 1998, Luteinizing hormone-releasing hormone is a primary signaling molecule in the neuroimmune network, Ann. N.Y. Acad. Sci., 840, 205, 10.1111/j.1749-6632.1998.tb09564.x

Marini, 1994, Direct antiproliferative effect of triptorelin on human breast cancer cells, Anticancer Res., 14, 1881

Martin, 1997, Role and regulation of phospholipase D signalling, Biochem. Soc. pans., 25, 1157, 10.1042/bst0251157

Martinez-Lorenzo, 1996, Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells, Immunology, 89, 511, 10.1046/j.1365-2567.1996.d01-782.x

Mason, 1988, Characterization of voltage-gated sodium channels in ovine gonadotrophs: Relationship to hormone secretion, J. Physiol., 399, 493, 10.1113/jphysiol.1988.sp017093

Mathias, 1998, Signal transduction of stress via ceramide, Biochem. J., 335, 465, 10.1042/bj3350465

Merrill, 1997, Sphingolipids-The enigmatic lipid class: Biochemistry, physiology, and pathophysiology, Toxicol. Appl. Pharmacol., 142, 208, 10.1006/taap.1996.8029

Miller, 1996, Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary, J. Clin. Endocrinol. Metab., 81, 80, 10.1210/jc.81.1.80

Minaretzis, 1995, Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells, J. Clin. Endocrinol. Metab., 80, 430, 10.1210/jc.80.2.430

Mizutani, 1998, Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate), J. Clin. Endocrinol. Metab., 83, 1253, 10.1210/jc.83.4.1253

Moore, 1998, The presence of a constitutively active phosphoinositide-3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway, Cancer Res., 58, 5239

Morris, 1997, Regulation and functions of phospholipase D, Biochem. Soc. Pans., 25, 1151, 10.1042/bst0251151

Müllen, 1991, Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of the cells in the G0/G1 phase of the cell cycle, Br. J. Cancer, 63, 930, 10.1038/bjc.1991.203

Müller, 1995, PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid, EMBO J., 14, 1961, 10.1002/j.1460-2075.1995.tb07188.x

Nagata, 1997, Apoptosis by death factor, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7

Nagata, 1995, The Fas death factor, Science, 267, 1449, 10.1126/science.7533326

Naor, 1990, Signal transduction mechanisms of Ca2∗ mobilizing hormones: The case of gonadotropin-releasing hormone, Endocr. Rev., 11, 326, 10.1210/edrv-11-2-326

Naor, 1998, Mechanism of GnRH receptor signaling: Combinatorial cross-talk of Ca2∗ and protein kinase C, Front. Neuroendocrinol., 19, 1, 10.1006/frne.1997.0162

Neer, 1995, Heterotrimeric G proteins: Organizers of transmembrane signals, Cell, 80, 249, 10.1016/0092-8674(95)90407-7

Nishizuka, 1995, Protein kinase C and lipid signaling for sustained cellular responses, FASEB J., 9, 197, 10.1096/fasebj.9.7.7737456

Ohno, 1993, Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma, Am. J. Obstet. Gynecol., 169, 605, 10.1016/0002-9378(93)90630-2

Oxford, 1993, Modulation of ion channels underlying excitation-secretion coupling in identified lactotrophs and gonadotrophs, Biol. Reprod., 48, 1, 10.1095/biolreprod48.1.1

Pan, 1992, G protein activation of a hormone-stimulated phosphatase in human tumor cells, Science, 256, 1215, 10.1126/science.256.5060.1215

Patel, 1996, The role of proteases during apoptosis, FASEB J., 10, 587, 10.1096/fasebj.10.5.8621058

Peng, 1994, Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells, Endocrinology, 135, 1740, 10.1210/en.135.5.1740

Pike, 1992, Phosphatidylinositol 4-kinases and the role of polyphosphoinositides in cellular regulation, Endocr. Rev., 13, 692, 10.1210/edrv-13-4-692

Pyne, 1997, Sphingolipids as differential regulators of cellular signalling processes, Biochem. Soc. Trans., 25, 549, 10.1042/bst0250549

Raid, 1993, Role of tyrosine kinase and phosphotyrosine phosphatase in growth of the intestinal crypt cell (IEC6) line, 202, 435

Roseff, 1990, Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women, Fertil. Steril., 54, 805, 10.1016/S0015-0282(16)53936-3

Runic, 1996, Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival, J. Clin. Endocrinol. Metab., 81, 3119, 10.1210/jc.81.8.3119

Sanno, 1997, Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries, J. Clin. Endocrinol. Metab., 82, 1974, 10.1210/jc.82.6.1974

Santana, 1995, Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells, Endocrinology, 136, 2345, 10.1210/en.136.5.2345

Santana, 1996, Interleukin-1 beta simulates sphingomyelin hydrolysis in cultured granulosa cells: Evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis, Endocrinology, 137, 2480, 10.1210/en.137.6.2480

Sato, 1995, FAP-1: A protein tyrosine phosphatase that associates with Fas, Science, 268, 411, 10.1126/science.7536343

Schally, 1994, Hypothalamic hormones: From neuroendocrinology to cancer therapy, Anticancer Drugs, 5, 115, 10.1097/00001813-199404000-00001

Schulze-Osthoff, 1994, Cell nucleus and DNA fragmentation are not required for apoptosis, J. Biol. Chem., 127, 15

Schwartzman, 1993, Apoptosis: The biochemistry and molecular biology of programmed cell death, Endocr. Rev., 14, 133

Sealfon, 1995, Functional domains of the gonadotropin-releasing hormone receptor, Cell. Mol. Neurobiol., 15, 25, 10.1007/BF02069557

Sealfon, 1997, Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor, Endocr. Rev., 18, 180, 10.1210/er.18.2.180

Sharoni, 1989, Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone, 86, 1648

Sherwood, 1993, Origin of mammalian gonadotropin-releasing hormones, Endocr. Rev., 14, 241, 10.1210/edrv-14-2-241

Sica, 1994, Combined effects of estradiol, leuprorelin, tamoxifen, and medroxyprogesterone acetate on cell growth and steroid receptors in breast cancer cells, J. Cancer Res. Clin. Oncol., 120, 605, 10.1007/BF01212815

Singer, 1997, Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D, Annu. Rev. Biochem., 66, 475, 10.1146/annurev.biochem.66.1.475

Sinha Hikim, 1997, Significance of apoptosis in the temporal and stage-specific loss of germ cells in the adult rat after gonadotropin deprivation, Biol. Reprod., 57, 1193, 10.1095/biolreprod57.5.1193

Spiegel, 1992, Receptor-effector coupling by G proteins: Implications for normal and abnormal signal transduction, Endocr. Rev., 13, 536, 10.1210/edrv-13-3-536

Spiegel, 1996, Sphingolipid metabolism and cell growth regulation, FASEB J., 10, 1388, 10.1096/fasebj.10.12.8903509

Stephens, 1993, Agonist-stimulated synthesis of phosphatidylinositol (3,4,5)-trisphosphate: Anew intracellular signalling system?, Biochim. Biophys. Acta, 1179, 27, 10.1016/0167-4889(93)90072-W

Stojilkovic, 1994, Gonadotropin-releasing hormone receptors: Structure and signal transduction pathways, Endocr. Rev., 15, 462, 10.1210/edrv-15-4-462

Strader, 1994, Structure and function of G protein-coupled receptors, Annu. Rev. Biochem., 63, 101, 10.1146/annurev.bi.63.070194.000533

Suda, 1993, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell, 75, 1169, 10.1016/0092-8674(93)90326-L

Takagi, 1995, Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas, Gynecol. Oncol., 58, 110, 10.1006/gyno.1995.1192

Takebayashi, 1996, Hormone-induced apoptosis by Fas-nuclear receptor fusion proteins: Novel biological tools for controlling apoptosis in vivo, Cancer Res., 56, 4164

Tanaka, 1995, Expression of the functional soluble form of human fas ligand in activated lymphocytes, EMBO J., 14, 1129, 10.1002/j.1460-2075.1995.tb07096.x

Tapanainen, 1993, Hormonal control of apoptotic cell death in the testis: Gonadotropins and androgens as testicular cell survival factors, Mol. Endocrinol., 7, 643, 10.1210/me.7.5.643

Testi, 1996, Sphingomyelin breakdown and cell fate, Trends Biochem. Sci., 21, 468, 10.1016/S0968-0004(96)10056-6

Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464

Vlahos, 1994, A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), J. Biol. Chem., 269, 5241, 10.1016/S0021-9258(17)37680-9

Walton, 1993, Protein tyrosine phosphatases, Anna. Rev. Biochem., 62, 101, 10.1146/annurev.bi.62.070193.000533

Wieder, 1997, Bcl-2 antagonizes apoptotic cell death induced by two new ceramide analogues, FEBS Lett., 411, 260, 10.1016/S0014-5793(97)00717-5

Witty, 1996, Induction of apoptotic cell death in hen granulosa cells by ceramide, Endocrinology, 137, 5269, 10.1210/en.137.12.5269

Yano, 1994, Inhibition of growth of OV 1063 human epithelial ovarian cancer xenografted in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75, 91, 7090

Yao, 1995, Ceramide-activated protein kinase is a Raf kinase, Nature, 378, 22689, 10.1038/378307a0

Yin, 1998, Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines, Life Sci., 62, 2015, 10.1016/S0024-3205(98)00173-8

Yonehara, 1989, A cell-killing monoclonal antibody (antiFas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J. Exp. Med., 169, 1747, 10.1084/jem.169.5.1747

Zheng, 1994, Sequential activation of phospholipase C and phospholipase D in agonist-stimulated gonadotrophs, Endocrinology, 134, 1446, 10.1210/en.134.3.1446